Tom Mander

Getting Smarter with Small Molecule Discovery: Lessons Learned With Tom Mander

The search for new small molecule therapeutics is becoming increasingly difficult as companies focus on more challenging targets. Tom Mander, Chief Executive Officer of Domainex, looks back on his career in small molecules and shares his hopes for the future – including how small molecules may finally be able to provide a breakthrough in Parkinson’s disease.